SARS-CoV-2 infection is associated with an increased risk of idiopathic acute pancreatitis but not pancreatic exocrine insufficiency or diabetes: long-term results of the COVIDPAN study
- PMID: 34764192
- DOI: 10.1136/gutjnl-2021-326218
SARS-CoV-2 infection is associated with an increased risk of idiopathic acute pancreatitis but not pancreatic exocrine insufficiency or diabetes: long-term results of the COVIDPAN study
Keywords: COVID-19; acute pancreatitis; pancreas.
Conflict of interest statement
Competing interests: None declared.
Comment on
-
SARS-CoV-2 infection in acute pancreatitis increases disease severity and 30-day mortality: COVID PAN collaborative study.Gut. 2021 Jun;70(6):1061-1069. doi: 10.1136/gutjnl-2020-323364. Epub 2021 Feb 5. Gut. 2021. PMID: 33547182 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous